This Core Support Center Grant (P30) application requests continued support for an analytic and synthetic chemistry laboratory and administrative shared core infrastructure. The participating, currently funded, constituent projects continue research programs with human laboratory and treatment clinic studies of the clinical pharmacology of abused drugs, pharmacotherapies and other treatment strategies to treat drug abuse and addictions. Drugs of interest to participating projects and assays available include nicotine and its metabolites, cocaine, methamphetamine and other phenethylamines, alcohol, MDMA, ephedra alkaloids, caffeine, gamma hydroxybutyrate (GHB), salvinorin, adenosine, and neurosteroids, and opiates. Analytical methods have been developed and validated in the core analytic laboratory to support studies with these drugs. Other new assays and labeled (deuterated) compounds will be made available to the associated research projects as needed. Disciplines represented by the participating projects and investigators include psychiatry, clinical psychology, neurology, general internal medicine, cardiology and clinical pharmacology, psychopharmacology, toxicology, genetics, pediatrics, pharmacy, organic, medicinal and analytical chemistry, and statistics.
Our aims are: (1) to provide a state-of-the-art well equipped and staffed, analytical and synthetic chemistry laboratory resource for the participating projects of drug abuse researchers at UCSF and at other institutions. (2) To provide administrative support for manuscript preparation, IRB and related regulatory documents, grants management, and other research administrative services of value participating projects. (3) To provide statistical consulting services regarding study design and data analysis strategies, particularly optimal pharmacokinetic analysis to participating projects. The overall objective is to provide sophisticated analytic laboratory resources with stability of support together with adequate administrative support responsive to the needs of individual funded constituent scientific projects as those projects change and evolve. This facility is a cost-effective shared laboratory resource that enhances and extends research possibilities of investigators currently funded by NIH or other federal or nonfederal sources to further our understanding of human psychoactive drug use, abuse and addiction, its health consequences and its treatment management.

Public Health Relevance

When researching the causes of drug addictions, measuring the health and other consequences of drug use, and searching for effective treatments for addicted people, measures of the amount of drug actually in a person's body are often important. This grant supports a state of the art analytic chemistry laboratory that provides, to a large number of research groups, innovative, sensitive, reliable and cost effective measures of commonly used drugs like nicotine, methamphetamine, opiates and other addicting drugs.

National Institute of Health (NIH)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Chiang, Nora
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
Schools of Medicine
San Francisco
United States
Zip Code
Benowitz, Neal L; Nardone, Natalie; Hatsukami, Dorothy K et al. (2015) Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 24:331-5
Benowitz, Neal L; Gan, Quan; Goniewicz, Maciej L et al. (2015) Different profiles of carcinogen exposure in Chinese compared with US cigarette smokers. Tob Control 24:e258-63
St Helen, Gideon; Benowitz, Neal L; Dains, Katherine M et al. (2014) Nicotine and carcinogen exposure after water pipe smoking in hookah bars. Cancer Epidemiol Biomarkers Prev 23:1055-66
Martins-Green, Manuela; Adhami, Neema; Frankos, Michael et al. (2014) Cigarette smoke toxins deposited on surfaces: implications for human health. PLoS One 9:e86391
Jones, Ian A; St Helen, Gideon; Meyers, Matthew J et al. (2014) Biomarkers of secondhand smoke exposure in automobiles. Tob Control 23:51-7
Goniewicz, Maciej Lukasz; Knysak, Jakub; Gawron, Michal et al. (2014) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 23:133-9
Zhu, Andy Z X; Zhou, Qian; Cox, Lisa Sanderson et al. (2014) Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes. Drug Metab Dispos 42:1971-7
Bahl, Vasundhra; Jacob 3rd, Peyton; Havel, Christopher et al. (2014) Thirdhand cigarette smoke: factors affecting exposure and remediation. PLoS One 9:e108258
St Helen, Gideon; Jacob 3rd, Peyton; Peng, Margaret et al. (2014) Intake of toxic and carcinogenic volatile organic compounds from secondhand smoke in motor vehicles. Cancer Epidemiol Biomarkers Prev 23:2774-82
Hsieh, S Jean; Zhuo, Hanjing; Benowitz, Neal L et al. (2014) Prevalence and impact of active and passive cigarette smoking in acute respiratory distress syndrome. Crit Care Med 42:2058-68

Showing the most recent 10 out of 127 publications